Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PERFORMANCE STUDY OF THE AL-SENSE

NCT02965430 is registered in ClinicalTrials.gov with Common Sense as lead sponsor.

NCT NCT02965430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02965430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PERFORMANCE STUDY OF THE AL-SENSE
Lead sponsor
Common Sense
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2016
Completion date
April 30, 2017
Enrollment
352 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

amniotic problems